Practice Change Page

Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39273.537778.AD (Published 06 September 2007) Cite this as: BMJ 2007;335:513

This article has a correction. Please see:

  1. Peter J Barnes, professor of thoracic medicine
  1. National Heart and Lung Institute, Imperial College, London
  1. P J Barnes, Airway Disease Section, National Heart and Lung Institute, Dovehouse St, London SW3 6LY p.j.barnes{at}imperial.ac.uk

    The clinical problem

    Asthma is one of the commonest chronic diseases worldwide and is effectively controlled in most patients with maintenance treatment. In those with moderate or severe persistent asthma, control may be achieved with an inhaled corticosteroid or a combination inhaler containing a corticosteroid and a long acting β2 agonist. The combination inhaler is more effective, but patients still require short acting β2 agonists such as salbutamol or terbutaline to relieve symptoms. I describe a new approach for acute exacerbation—SMART (single inhaler maintenance and reliever therapy). This uses the combination inhaler, rather than the short acting β2 agonist, as the reliever.

    The evidence for change

    Using a formulation of budesonide plus formoterol (budesonide/formoterol) both as a reliever and as maintenance therapy once or twice daily is more effective in controlling asthma than conventional approaches using budesonide/formoterol, fluticasone/salmeterol, or high dose corticosteroids (budesonide or fluticasone) as the maintenance treatment with short acting β2 agonists as relievers (table).1 2 3 4 5 The most striking benefits are fewer exacerbations (severe exacerbations, defined as needing a course of oral corticosteroids, are …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe